FREE COMMUNICATION 10

17.00-18.30   G106-G107

 

CKD Anaemia
 

Chairs: Carlo Gaillard, Groningen, The Netherlands
            Iain C. Macdougall, London, UK
  
FREE COMMUNICATIONS
 
SO048
IV FERRIC CARBOXYMALTOSE (FCM) IS A CONVENIENT AND WELL-TOLERATED FIRST-LINE THERAPY FOR THE TREATMENT OF ANAEMIA IN PATIENTS WITH IRON DEFICIENCY AND NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE (ND-CKD): RESULTS OF THE RANDOMISED FIND-CKD STUDY SD
Roger1, A Bock2, F Carrera3, K-U Eckardt4, C Gaillard5, D Van Wyck6, B Roubert7, J Nolen7, IC Macdougall8 1Renal Research, Gosford, Australia, 2Kantonsspital, Aarau, Switzerland, 3Eurodial, Leiria, Portugal, 4Univ Erlangen-Nuremberg, Erlangen, Germany, 5Univ Medical Centre, Groningen, Netherlands, 6Davita Healthcare Partners Inc, Denver, CO; 7Vifor Pharma, Glattbrugg, Switzerland, 8King’s College Hosp, London, UK
   
SO049
INTRAVENOUS FERRIC CARBOXYMALTOSE VS ORAL IRON IN ANAEMIC PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY: RESULTS OF THE RANDOMISED FIND-CKD STUDY IC
Macdougall1, A Bock2, F Carrera3, K-U Eckardt4, C Gaillard5, D Van Wyck6, B Roubert7, J Nolen7, SD Roger8 1King’s College Hosp, London, UK, 2Kantonsspital, Aarau, Switzerland, 3Eurodial, Leiria, Portugal, 4Univ Erlangen-Nuremberg, Erlangen, Germany, 5Univ Medical Centre, Groningen, Netherlands, 6Davita Healthcare Partners Inc, Denver, CO; 7Vifor Pharma, Glattbrugg, Switzerland, 8Renal Research, Gosford, Australia
  
SO050
ENDOTHELIAL DYSFUNCTION AND RENAL TUBULAR DAMAGE AFTER INTRAVENOUS IRON INFUSION IN NON-DIALYSIS CKD PATIENTS
Gabriel Mircescu1,2 Cristina Capusa1,2, Diana Margarit2, Liliana Barsan2, Violeta Blaga2, Simona Stancu1,2 1Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania, 2Dr. Carol Davila Teaching Hosp Nephrology, Bucharest, Romania SO051 CONTROLLED HEMOGLOBIN RESPONSE IN A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF AKB-6548 IN SUBJECTS WITH CHRONIC KIDNEY DISEASE Charlotte S Hartman, Isaiah R Shalwitz, Robert A Shalwitz Akebia Therapeutics, Inc., Cambridge, MA
  
SO052
BONE ERYTHROPOIETIN RECEPTOR IS DEPRESSED IN ANEMIA OF CHRONIC KIDNEY DISEASE
Lital London1,2, Yael Segev1,2, Daniel Landau3,2 1Ben Gurion Univ Negev, Beer-Sheva, Israel, 2Soroka Univ Medical Center, Beer-Sheva, Israel, 3Soroka Medical Center, Beer-Sheva, Israel
  

SO053
EFFECT OF INTRAVENOUS FERRIC CARBOXYMALTOSE IN THE MANAGEMENT OF IRON DEFICIENCY ANEMIA, HOMOCYSTEINE (HCY) LEVELS AND CARDIAC FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD)
Afroditi Vlachopanou1, Petros Nikolopoulos2, Theodora Bampali1, Valerios Foulidis1, Konstantinos Katopodis1, Chariklia Gouva1 1General Hosp Arta, Greece, 2General Hosp Syros, Syros, Greece

 
back to the timetable